Drug Trial Radar · NCT02944214
Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients
Last checked: Nov 20, 2026Latest source record: Oct 25, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
800
Planned (sponsor's estimate)
Start
Oct 2016
Primary completion
Dec 2019
Study completion Dec 2019
Sponsor
- Lead sponsor
- Shanghai 10th People's HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 25, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether febuxostat and benzbromarone could protect renal function in chinese, and which one could be better.
Conditions
- Chronic Kidney Disease
- Hyperuricemia
- Abnormal Renal Function
Interventions
FebuxostatDrug
It acts as an inhibitor of xanthine oxidase, thus lowering urate concentrations in the body
BenzbromaroneDrug
It is structurally related to the antiarrhythmic amiodarone, and it is a uricosuric agent and non-competitive inhibitor of xanthine oxidase
Primary outcomes
What the sponsor says the trial is designed to measure.
- serum creatinine, estimated glomerular filtration rate (eGFR)Time frame: up to 12th months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.